Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Natera Inc
(NQ:
NTRA
)
102.67
+0.52 (+0.51%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,047,586
Open
102.18
Bid (Size)
102.62 (18)
Ask (Size)
102.68 (91)
Prev. Close
102.15
Today's Range
101.16 - 104.58
52wk Range
36.90 - 117.23
Shares Outstanding
122,802,694
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
New MultiCenter Prospective Study Demonstrates Signatera’s Clinical Utility in Merkel Cell Carcinoma
July 26, 2024
From
Natera, Inc.
Via
Business Wire
(NTRA) - Analyzing Natera's Short Interest
July 23, 2024
Via
Benzinga
Performance
YTD
+65.81%
+65.81%
1 Month
-7.83%
-7.83%
3 Month
+12.01%
+12.01%
6 Month
+56.89%
+56.89%
1 Year
+126.54%
+126.54%
More News
Read More
Here's How Much You Would Have Made Owning Natera Stock In The Last 5 Years
July 18, 2024
Via
Benzinga
The 3 Best Gene Editing Stocks to Buy in July 2024
July 08, 2024
Via
InvestorPlace
$1000 Invested In This Stock 5 Years Ago Would Be Worth $4,300 Today
July 04, 2024
Via
Benzinga
$100 Invested In Natera 5 Years Ago Would Be Worth This Much Today
June 20, 2024
Via
Benzinga
$1000 Invested In This Stock 5 Years Ago Would Be Worth $4,400 Today
June 13, 2024
Via
Benzinga
Breaking Down Natera: 10 Analysts Share Their Views
June 03, 2024
Via
Benzinga
Natera to Present at the 28th International Conference on Prenatal Diagnosis and Therapy
July 03, 2024
From
Natera, Inc.
Via
Business Wire
Trading SMID Biotech Stocks In A Volatile Market
July 01, 2024
Via
Talk Markets
Natera Announces DECIPHER: A Phase II, Single-Arm Adjuvant Trial in Gastroesophageal Cancer
June 27, 2024
From
Natera, Inc.
Via
Business Wire
(NTRA) - Analyzing Natera's Short Interest
May 31, 2024
Via
Benzinga
Key Takeaways From Natera Analyst Ratings
May 13, 2024
Via
Benzinga
Myriad Genetics Sees Stock Surge with Hereditary Cancer Tests
June 18, 2024
Via
MarketBeat
Natera Launches Differentiated New Feature for Prospera™ Heart Test, Enhancing Detection of Rejection for Transplant Patients
June 17, 2024
From
Natera, Inc.
Via
Business Wire
Amazon, Natera And A Financial Stock: CNBC's 'Final Trades'
June 11, 2024
Via
Benzinga
Natera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
June 03, 2024
From
Natera, Inc.
Via
Business Wire
Cathie Wood-Led Ark Invest Sells Nearly $28M Worth Of Robinhood Shares Amid Crypto API Launch And Lackluster Bitcoin Price Action
May 30, 2024
Via
Benzinga
Natera Presents Latest in Transplant Innovation Data Across Multiple Organs at ATC 2024
May 30, 2024
From
Natera, Inc.
Via
Business Wire
Ford Motor, Microsoft And 2 Other Stocks Insiders Are Selling
May 28, 2024
Via
Benzinga
Natera to Present at the 2024 Leerink Partners Healthcare Crossroads Conference
May 23, 2024
From
Natera, Inc.
Via
Business Wire
Natera Announces New MRD Data in Multiple Tumor Types, to be Presented at ASCO Annual Meeting
May 23, 2024
From
Natera, Inc.
Via
Business Wire
NATERA ALERT: Bragar Eagel & Squire, P.C. is Investigating Natera, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
May 14, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Planet Fitness To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Tuesday
May 14, 2024
Via
Benzinga
Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
May 10, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.